XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat: moderate to severe persistent asthma in people 6 years of age and older whose asthma …
Allergic Asthma | XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat moderate to severe persistent asthma in people 6 years of age and older whose asthma …
Using Xolair® (omalizumab) For Chronic Hives Treatment
Learn about XOLAIR® (omalizumab) as a treatment option for chronic hives, also known as chronic spontaneous urticaria (CSU). See full prescribing, safety, & Boxed Warning info.
Starting XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat moderate to severe persistent asthma in people 6 years of age and older whose asthma …
Dosing and Administration | XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat moderate to severe persistent asthma in people 6 years of age and older whose asthma …
Side Effects | XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat chronic spontaneous urticaria (CSU, previously referred to as chronic idiopathic urticaria (CIU), …
Allergic Asthma Treatment | XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat moderate to severe persistent asthma in people 6 years of age and older whose asthma …
Starting XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat chronic spontaneous urticaria (CSU, previously referred to as chronic idiopathic urticaria (CIU), …
Dosing and Administration | Autoinjector | XOLAIR® (omalizumab)
XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat moderate to severe persistent asthma in people 6 years of age and older whose asthma …
CSU Chronic Hives Treatment | XOLAIR® (omalizumab)
XOLAIR® (omalizumab) is approved to treat chronic hives, also known as chronic spontaneous urticaria (CSU), when H1 antihistamines are not providing relief in patients 12 years and older. …